Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats

OBJECTIVE: Recent studies have demonstrated that gut microbiota was closely related to metabolic disorders such as type 2 diabetes. Oral antidiabetic medications including metformin, acarbose and sitagliptin lowered blood glucose levels via acting on the gastrointestinal tract. The aim of the study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Minchun, Feng, Rilu, Yang, Mei, Qian, Cheng, Wang, Zheng, Liu, Wei, Ma, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777410/
https://www.ncbi.nlm.nih.gov/pubmed/31641523
http://dx.doi.org/10.1136/bmjdrc-2019-000717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777410/
https://www.ncbi.nlm.nih.gov/pubmed/31641523
http://dx.doi.org/10.1136/bmjdrc-2019-000717

Ejemplares similares